Ipilimumab

Tax included
Ipilimumab is a fully human monoclonal antibody IgG1κ that blocks the inhibitory receptor cytotoxic T lymphocyte antigen 4 (CTLA-4) on T cells. Ipilimumab can be used in unresectable or metastatic melanoma (MM) studies.
MedChemExpress 
HY-P9901

Data sheet

Size
Multiple sizes
Reactivity
CTLA-4
Application
Cancer-programmed cell death
CAS
477202-00-9